loading...

F.D.A. authorizes another antibody treatment for high-risk Covid patients.


The drug, from GlaxoSmithKline and Vir, aims to keep Covid patients out of the hospital. New York Times By BY REBECCA ROBBINS from NYT Business https://ift.tt/3yFK0IV
Drugs (Pharmaceuticals), Antibodies, Coronavirus (2019-nCoV)

Comments